Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPOBy Mario Cazombo / April 17, 2026 Kailera Therapeutics Inc. shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized US initial public offering.
Frankenstein’s Index Fund August 6, 2025 / Alternative Investments, Drivers of Value, Economics, General, Investment Topics, Performance Measurement & Evaluation
How GenAI-Powered Synthetic Data Is Reshaping Investment Workflows August 6, 2025 / Artificial Intelligence, Drivers of Value, Future States, General, Investment Topics, Philosophy
